London School of Hygiene & Tropical Medicine
Investigational Medicinial Product (IMP) - IM Woman Trial
This is a large award for Medical Equipment & Pharmaceuticals — above three-quarters of comparable contracts. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Provision of treatment kit boxes required for 4 campaigns with approximately 10,000 patient packs per campaign.
Recruitment period is 24 months - campaign approximately once every 6 months commencing March 2023.
Make the case to bid
Reveal who to approach at London School of Hygiene & Tropical Medicine, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- d9d3f59a-3177-4b49-b2a1-9ac58d74771f
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- 20211122190045-104519
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
Assembling the market network…
London School of Hygiene & Tropical Medicine’s tender network
Assembling the network…